Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
---|
02/01/2001 | WO2001007659A2 Methods for identifying inhibitors of signaling molecules |
02/01/2001 | WO2001007441A1 8-PHENYL-6,9-DIHYDRO-[1,2,4]TRIAZOLO[3,4-i]PURIN-5-ONE DERIVATIVES |
02/01/2001 | WO2001007440A1 Imidazoimidazoles and triazoles as anti-inflammatory agents |
02/01/2001 | WO2001007411A1 Biarylurea derivatives |
02/01/2001 | WO2001007052A1 Small molecules useful in the treatment of inflammatory disease |
02/01/2001 | WO2001007020A2 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof |
02/01/2001 | WO2000061585A3 1,3-dipolar cycloadditions to polypyrrolic macrocycles |
02/01/2001 | DE19935219A1 Carbonsäureamide, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung Carboxamides, medicaments containing these compounds, their use and production |
02/01/2001 | CA2383017A1 Imidazoimidazoles and triazoles as anti-inflammatory agents |
02/01/2001 | CA2380389A1 Biarylurea derivatives |
02/01/2001 | CA2380181A1 8-phenyl-6,9-dihydro-¬1,2,4|triazolo¬3,4-i|purin-5-one derivatives |
02/01/2001 | CA2380179A1 Methods for identifying cellular responses attributable to signaling molecule inhibition and inhibitors thereof |
01/31/2001 | EP1071683A1 New compounds |
01/31/2001 | EP1071666A1 Azacycloalkane derivatives, preparation and therapeutic application |
01/31/2001 | EP1071474A1 Substituted porphyrins |
01/31/2001 | EP1071427A1 Intermittent claudication therapeutic drugs comprising pyrroloazepines |
01/31/2001 | CN1282248A Combination effective for treatment of impotence |
01/31/2001 | CN1281851A Useful sypolyphenol intermediate and its preparation method |
01/31/2001 | CN1061350C 2.7-substituted octahydro-pyrrolo (1.2-A) pyrazine derivatives |
01/30/2001 | US6180643 Antagonist of interleukins, tumor necrosis factor |
01/30/2001 | US6180636 Substituted pyrrolopyrimidines and processes for their preparation |
01/30/2001 | US6180630 Tricyclic pyrazolo-pyridazinone analogues as GAGA-A receptor ligands |
01/30/2001 | US6180621 Administering to warm-blooded animals for treatment and prevention of infectious diseases caused by helicobacter pylori |
01/30/2001 | US6180567 Reacting 2-alkoxycarbonyl-benzenesulfonamide derivative with 1,2,4-(1h)triazole-5-(thi)one derivative |
01/30/2001 | US6180551 Enantioselective dihydroxylation |
01/30/2001 | CA2053268C Bacteriochlorophyll-a derivatives useful in photodynamic therapy |
01/30/2001 | CA2030361C 3-fluorosulfonyloxyceph-3-em displacement process |
01/25/2001 | WO2001005794A2 Method for making debromohymenialdisine and analogs thereof |
01/25/2001 | WO2001005793A1 1,2,3,4,5,6-HEXAHYDROAZEPINO[4,5-b]INDOLES CONTAINING ARYLSULFONES AT THE 9-POSITION |
01/25/2001 | WO2001005792A1 Anti-inflammatory oxo derivatives and hydroxy derivatives of pyrrolizines, and their pharmaceutical use |
01/25/2001 | WO2001005790A1 New compounds |
01/25/2001 | WO2001005772A1 Pyrazinones, compositions containing such compounds |
01/25/2001 | WO2000066587A3 Polyamines and their use in therapy |
01/25/2001 | DE19933850A1 Preparation of pure triethylenediamine solution and crystals, useful as catalyst for polyurethane foam production, comprises vaporization, passing vapor into liquid solvent and crystallization from solution |
01/25/2001 | CA2379847A1 Method for making debromohymenialdisine and analogs thereof |
01/25/2001 | CA2378202A1 New compounds |
01/25/2001 | CA2377718A1 1,2,3,4,5,6-hexahydroazepino¬4,5-b|indoles containing arylsulfones at the 9-position |
01/24/2001 | EP1070717A1 Process for the preparation of pure Triethylenediamine |
01/24/2001 | EP1070537A2 Oxygen-selective adsorbents |
01/24/2001 | EP1070083A1 Crystalline forms of 1s- 1alpha (2s*,3r*), 9alpha]-6, 10-dioxo-n- (2-ethoxy-5 -oxo-tetrahydro-3 -furanyl) -9- (1-isoquinolyl) carbonyl]-amino] octahydro-6h -piridazino 1, 2-a] 1,2] diazepin- 1-carboxamide |
01/24/2001 | EP1070068A1 Granulatimide derivatives for use in cancer treatment |
01/24/2001 | EP1070067A1 Cytotoxic alkaloid derivatives including asmarine a and b isolated from a sponge |
01/24/2001 | EP1070066A1 SUBSTITUTED 1,2,4-TRIAZOLO 3,4-a]PYRIDAZINE |
01/24/2001 | EP0667349B1 Depression remedy |
01/24/2001 | CN1281458A Purine compounds having PDE IV inhibitory activity and methods of synthesis |
01/24/2001 | CN1281439A 4-Hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents |
01/24/2001 | CN1281430A N-alkanoylphenylalanine derivatives |
01/24/2001 | CN1280981A Racemization of R,S-dioxo-benzyl pyrrolopiperidine |
01/24/2001 | CN1061044C Tricyclic 5,6-dihydro-9H-pyrazolo [3,4-C]-1,2,4-triaolo [4,3-alpha] pyridines |
01/23/2001 | US6177565 Process for synthesizing piperazic acid |
01/23/2001 | US6177561 Preparation of acid amides and metallization of compounds |
01/23/2001 | US6177451 For humans; parkinson's, tourelle's, and alzheimer's diseases |
01/23/2001 | US6177431 Agricultural pesticides effective against insects, arachnids, nematodes |
01/23/2001 | US6177428 Treatment of sexual dysfunction; stimulation of endogenous nitrogen monoxide synthesis |
01/23/2001 | US6177425 Stereospecific enantiomer having antiinflammatory and neutrophil elastase inhibiting activity; for treatment of chronic bronchitis in humans or animals |
01/23/2001 | US6177401 Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis |
01/23/2001 | US6177379 Containing diels-alder adduct obtained by reacting specified azo compound and conjugated diene |
01/23/2001 | US6177280 Ricin inhibitors and methods for use thereof |
01/23/2001 | US6177060 Nmr or x-ray lymphography images |
01/23/2001 | CA2033479C Process for preparing (1r,5s,6s)-2-[(6,7-dihydro-5h-pyrazolo[1,2-a][1,2,4] triazolium-6-yl)] thio-6- [(r)-1-hydroxyethyl] -1-methyl-carbapenem-3-carboxylate and starting materialsthereof |
01/23/2001 | CA2031079C Aminocarbonylcarbamates related to physostigmine, a process for their preparation and their use as medicaments |
01/18/2001 | WO2001004105A1 Method for preparing 2-(2-arylmorpholin-2-yl)ethanol derivatives and intermediates |
01/18/2001 | WO2001004102A1 Quinazoline derivatives |
01/18/2001 | WO2001003644A2 Pyrazolopyrimidinone derivatives conjugated to thiophene moieties or benzo [fused] 5-membered heterocycles for erectile dysfunction |
01/18/2001 | WO2000066099A3 Compositions comprising phosphodiesterase inhabitors for the treatment of sexual disfunction |
01/18/2001 | WO1999064049A9 Novel antibacterial agents |
01/18/2001 | DE19930736A1 Verfahren zur Herstellung von Triethylendiamin unter Einsatz von Ethylendiamin A process for preparing triethylenediamine from ethylenediamine using |
01/18/2001 | CA2378291A1 Quinazoline derivatives |
01/17/2001 | EP1069132A1 Bicyclic derivatives of amino-pyrazinones, process of preparation and pharmaceutical compositions comprising them |
01/17/2001 | EP1069126A1 Triazolopurine derivatives, medicinal composition containing the derivatives, adenosine a3 receptor compatibilizing agent, and asthmatic remedy |
01/17/2001 | EP1069125A2 Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs, a process for their preparation and their use as medicaments |
01/17/2001 | EP1069124A1 2-Benzimidazolylamine compounds as ORL1-receptor agonists |
01/17/2001 | EP1068272A2 Improved method of making sulfanatophenyl substituted porphines |
01/17/2001 | EP1068207A1 AMINOALKYL SUBSTITUTED 9H-PYRIDINO 2,3-b]INDOLE AND 9H-PYRIMIDINO 4,5-b]INDOLE DERIVATIVES |
01/17/2001 | EP1068206A1 Aminoalkyl substituted pyrrolo 2,3-b]pyridine and pyrrolo 2,3-d]pyrimidine derivatives: modulators of crf1 receptors |
01/17/2001 | EP1068205A1 Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino 2,3-b]indole and 5,6,7,8-tetrahydro-9h-pyrimidino 4,5-b]indole derivatives: crf1 specific ligands |
01/17/2001 | EP1068195A1 Antagonists of gonadotropin releasing hormone |
01/17/2001 | EP1067894A2 Protease inhibitors |
01/17/2001 | EP1015430A4 Spiro pyrrolidine-2,3'-oxindole] compounds and methods of use |
01/17/2001 | CN1280568A Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
01/17/2001 | CN1060776C Procell for manufactare of imidazo benzodiazepine derivatives |
01/17/2001 | CN1060774C Process for preparation of enantionerically pure imidazolyl compounds |
01/17/2001 | CN1060768C Pyrazoles and pyrazolopyrimidines |
01/16/2001 | US6175014 Process for the preparation of lactam derivatives |
01/16/2001 | US6174915 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses |
01/16/2001 | US6174912 Nitrogen substituted imidazo[4,5-C]pyrazoles as corticotropin releasing hormone antagonists |
01/16/2001 | US6174888 Potent purine nucleoside phosphorylase inhibitors; inhibitors of t-cell formation, i.e., immunosuppressants; transplant rejection; autoimmune diseases, e.g., rheumatoid diseases, psoriasis, dermatitis, crohn's disease, uveitis; |
01/16/2001 | US6174884 1,5-dihydro-pyrazolo[34-D]-pyrimidinone derivatives |
01/16/2001 | US6174881 Hydroxymethylimidazodiazepines and their esters |
01/16/2001 | US6174839 As herbicide |
01/16/2001 | CA2314008A1 2-benzimidazolylamine compounds as orl1-receptor agonists |
01/16/2001 | CA2223404C Novel crystal form of anhydrous 7-(¬1.alpha., 5.alpha., 6.alpha.|-6-amino-3-azabicyclo¬3.1.0|hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid, methanesulfonic acid salt |
01/11/2001 | WO2001003126A2 High density non-volatile memory device |
01/11/2001 | WO2001002406A1 Potassium channel blocking agents |
01/11/2001 | WO2001002405A1 Quinuclidine derivatives for treatment of neurological disorders |
01/11/2001 | WO2001002404A2 Method for producing triethylene diamine, using ethylene diamine |
01/11/2001 | WO2001002403A1 METHOD FOR PREPARING SUBSTITUTED [1,4]DIAZEPINO[6,7,1-hi]INDOL-4-ONES |
01/11/2001 | WO2001002402A1 Process for the preparation of midazolam |
01/11/2001 | WO2001002374A1 Bridged fluorescent dyes, their preparation and their use in assays |
01/11/2001 | WO2001002373A1 Dihydrobenzodiazepins and their use for treating dyslipidemia |